The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese

Citation
Js. Lin et al., The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese, THROMB RES, 97(3), 2000, pp. 89-94
Citations number
22
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
THROMBOSIS RESEARCH
ISSN journal
00493848 → ACNP
Volume
97
Issue
3
Year of publication
2000
Pages
89 - 94
Database
ISI
SICI code
0049-3848(20000201)97:3<89:TPOCMI>2.0.ZU;2-#
Abstract
C677T mutation of the methylenetetrahydrofolate reductase gene remains a co ntroversial risk factor for venous thrombosis in Whites. The prevalence of methylenetetrahydrofolate reductase C677T genotype and its association with vascular thrombosis are not well established in Chinese population. We con ducted a case-control study to investigate the prevalence of methylenetetra hydrofolate reductase C677T gene mutation and its association with venous t hrombophilia in Taiwanese Chinese. The subjects consisted of 112 venous thr ombophilic patients and 125 healthy controls, with similar age (p = 0.08) a nd sex (p = 0.58). The prevalent rates of C/T heterozygote were 32.8 and 44 .6%; whereas those of T/T homozygote were 6.4 and 8.0% in the controls and patients, respectively. Neither C/T heterozygote (odds ratio, 1.7; 95% conf idence interval, 1.0-3.0, p = 0.05) nor T/T homozygote (odds ratio, 1.4; 95 % confidence interval, 0.5-4.0, p = 0.5) was significantly associated with venous thrombosis. Even when only subjects (52 patients and 107 controls) w ith normal inhibitor protein levels were analyzed, the association of T/T h omozygote with venous thrombosis remained insignificant (p = 0.06) with an odds ratio (95% confidence interval) of 3.4 (0.99-11.7). We concluded that, in Taiwanese Chinese, methylenetetrahydrofolate reductase C677T mutation i s a common genetic mutation, but T/T homozygote is not a significant risk f actor for venous thrombophilia. (C) 2000 Elsevier Science Ltd. All rights r eserved.